178 related articles for article (PubMed ID: 24764580)
1. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
[TBL] [Abstract][Full Text] [Related]
2. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Hampras SS; Sucheston-Campbell LE; Cannioto R; Chang-Claude J; Modugno F; Dörk T; Hillemanns P; Preus L; Knutson KL; Wallace PK; Hong CC; Friel G; Davis W; Nesline M; Pearce CL; Kelemen LE; Goodman MT; Bandera EV; Terry KL; Schoof N; Eng KH; Clay A; Singh PK; Joseph JM; Aben KK; Anton-Culver H; Antonenkova N; Baker H; Bean Y; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bruinsma F; Butzow R; Campbell IG; Carty K; Cook LS; Cramer DW; Cybulski C; Dansonka-Mieszkowska A; Dennis J; Despierre E; Dicks E; Doherty JA; du Bois A; Dürst M; Easton D; Eccles D; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Gronwald J; Harrington P; Harter P; Hasmad HN; Hein A; Heitz F; Hildebrandt MA; Hogdall C; Hogdall E; Hosono S; Iversen ES; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kellar M; Kelley JL; Kiemeney LA; Klapdor R; Kolomeyevskaya N; Krakstad C; Kjaer SK; Kruszka B; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lissowska J; Liu S; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Moes-Sosnowska J; Narod SA; Nedergaard L; Nevanlinna H; Nickels S; Olson SH; Orlow I; Weber RP; Paul J; Pejovic T; Pelttari LM; Perkins B; Permuth-Wey J; Pike MC; Plisiecka-Halasa J; Poole EM; Risch HA; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schmitt K; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Tangen IL; Teo SH; Thompson PJ; Timorek A; Tsai YY; Tworoger SS; Tyrer J; van Altena AM; Vergote I; Vierkant RA; Walsh C; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Gayther SA; Ramus SJ; Sellers TA; Schildkraut JM; Phelan CM; Berchuck A; Chenevix-Trench G; Cunningham JM; Pharoah PP; Ness RB; Odunsi K; Goode EL; Moysich KB
Oncotarget; 2016 Oct; 7(43):69097-69110. PubMed ID: 27533245
[TBL] [Abstract][Full Text] [Related]
3. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
Sieh W; Köbel M; Longacre TA; Bowtell DD; deFazio A; Goodman MT; Høgdall E; Deen S; Wentzensen N; Moysich KB; Brenton JD; Clarke BA; Menon U; Gilks CB; Kim A; Madore J; Fereday S; George J; Galletta L; Lurie G; Wilkens LR; Carney ME; Thompson PJ; Matsuno RK; Kjær SK; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Vierkant RA; Cunningham JM; Brinton LA; Yang HP; Sherman ME; García-Closas M; Lissowska J; Odunsi K; Morrison C; Lele S; Bshara W; Sucheston L; Jimenez-Linan M; Driver K; Alsop J; Mack M; McGuire V; Rothstein JH; Rosen BP; Bernardini MQ; Mackay H; Oza A; Wozniak EL; Benjamin E; Gentry-Maharaj A; Gayther SA; Tinker AV; Prentice LM; Chow C; Anglesio MS; Johnatty SE; Chenevix-Trench G; Whittemore AS; Pharoah PD; Goode EL; Huntsman DG; Ramus SJ
Lancet Oncol; 2013 Aug; 14(9):853-62. PubMed ID: 23845225
[TBL] [Abstract][Full Text] [Related]
4. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Block MS; Charbonneau B; Vierkant RA; Fogarty Z; Bamlet WR; Pharoah PD; ; ; ; Rossing MA; Cramer D; Pearce CL; Schildkraut J; Menon U; Kjaer SK; Levine DA; Gronwald J; Culver HA; Whittemore AS; Karlan BY; Lambrechts D; Wentzensen N; Kupryjanczyk J; Chang-Claude J; Bandera EV; Hogdall E; Heitz F; Kaye SB; Fasching PA; Campbell I; Goodman MT; Pejovic T; Bean YT; Hays LE; Lurie G; Eccles D; Hein A; Beckmann MW; Ekici AB; Paul J; Brown R; Flanagan JM; Harter P; du Bois A; Schwaab I; Hogdall CK; Lundvall L; Olson SH; Orlow I; Paddock LE; Rudolph A; Eilber U; Dansonka-Mieszkowska A; Rzepecka IK; Ziolkowska-Seta I; Brinton LA; Yang H; Garcia-Closas M; Despierre E; Lambrechts S; Vergote I; Walsh CS; Lester J; Sieh W; McGuire V; Rothstein JH; Ziogas A; Lubiński J; Cybulski C; Menkiszak J; Jensen A; Gayther SA; Ramus SJ; Gentry-Maharaj A; Berchuck A; Wu AH; Pike MC; Van Den Berg D; Terry KL; Vitonis AF; Ramirez SM; Rider DN; Knutson KL; Sellers TA; Phelan CM; Doherty JA; Johnatty SE; deFazio A; Song H; Tyrer J; Kalli KR; Fridley BL; Cunningham JM; Goode EL
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1421-7. PubMed ID: 24740199
[TBL] [Abstract][Full Text] [Related]
5. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.
Yarmolinsky J; Relton CL; Lophatananon A; Muir K; Menon U; Gentry-Maharaj A; Walther A; Zheng J; Fasching P; Zheng W; Yin Ling W; Park SK; Kim BG; Choi JY; Park B; Davey Smith G; Martin RM; Lewis SJ
PLoS Med; 2019 Aug; 16(8):e1002893. PubMed ID: 31390370
[TBL] [Abstract][Full Text] [Related]
6. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
Chornokur G; Lin HY; Tyrer JP; Lawrenson K; Dennis J; Amankwah EK; Qu X; Tsai YY; Jim HS; Chen Z; Chen AY; Permuth-Wey J; Aben KK; Anton-Culver H; Antonenkova N; Bruinsma F; Bandera EV; Bean YT; Beckmann MW; Bisogna M; Bjorge L; Bogdanova N; Brinton LA; Brooks-Wilson A; Bunker CH; Butzow R; Campbell IG; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Cybulski C; Dansonka-Mieszkowska A; du Bois A; Despierre E; Dicks E; Doherty JA; Dörk T; Dürst M; Easton DF; Eccles DM; Edwards RP; Ekici AB; Fasching PA; Fridley BL; Gao YT; Gentry-Maharaj A; Giles GG; Glasspool R; Goodman MT; Gronwald J; Harrington P; Harter P; Hein A; Heitz F; Hildebrandt MA; Hillemanns P; Hogdall CK; Hogdall E; Hosono S; Jakubowska A; Jensen A; Ji BT; Karlan BY; Kelemen LE; Kellar M; Kiemeney LA; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Le ND; Lee AW; Lele S; Leminen A; Lester J; Levine DA; Liang D; Lim BK; Lissowska J; Lu K; Lubinski J; Lundvall L; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; McNeish I; Menon U; Milne RL; Modugno F; Moysich KB; Ness RB; Nevanlinna H; Eilber U; Odunsi K; Olson SH; Orlow I; Orsulic S; Weber RP; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Risch HA; Rosen B; Rossing MA; Rothstein JH; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schernhammer E; Schwaab I; Shu XO; Shvetsov YB; Siddiqui N; Sieh W; Song H; Southey MC; Spiewankiewicz B; Sucheston L; Teo SH; Terry KL; Thompson PJ; Thomsen L; Tangen IL; Tworoger SS; van Altena AM; Vierkant RA; Vergote I; Walsh CS; Wang-Gohrke S; Wentzensen N; Whittemore AS; Wicklund KG; Wilkens LR; Wu AH; Wu X; Woo YL; Yang H; Zheng W; Ziogas A; Hasmad HN; Berchuck A; ; ; Iversen ES; Schildkraut JM; Ramus SJ; Goode EL; Monteiro AN; Gayther SA; Narod SA; Pharoah PD; Sellers TA; Phelan CM
PLoS One; 2015; 10(6):e0128106. PubMed ID: 26091520
[TBL] [Abstract][Full Text] [Related]
7. Inherited variants in regulatory T cell genes and outcome of ovarian cancer.
Goode EL; DeRycke M; Kalli KR; Oberg AL; Cunningham JM; Maurer MJ; Fridley BL; Armasu SM; Serie DJ; Ramar P; Goergen K; Vierkant RA; Rider DN; Sicotte H; Wang C; Winterhoff B; Phelan CM; Schildkraut JM; Weber RP; Iversen E; Berchuck A; Sutphen R; Birrer MJ; Hampras S; Preus L; Gayther SA; Ramus SJ; Wentzensen N; Yang HP; Garcia-Closas M; Song H; Tyrer J; Pharoah PP; Konecny G; Sellers TA; Ness RB; Sucheston LE; Odunsi K; Hartmann LC; Moysich KB; Knutson KL
PLoS One; 2013; 8(1):e53903. PubMed ID: 23382860
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL
Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430
[TBL] [Abstract][Full Text] [Related]
9. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer.
Schildkraut JM; Goode EL; Clyde MA; Iversen ES; Moorman PG; Berchuck A; Marks JR; Lissowska J; Brinton L; Peplonska B; Cunningham JM; Vierkant RA; Rider DN; Chenevix-Trench G; Webb PM; Beesley J; Chen X; Phelan C; Sutphen R; Sellers TA; Pearce L; Wu AH; Van Den Berg D; Conti D; Elund CK; Anderson R; Goodman MT; Lurie G; Carney ME; Thompson PJ; Gayther SA; Ramus SJ; Jacobs I; Krüger Kjaer S; Hogdall E; Blaakaer J; Hogdall C; Easton DF; Song H; Pharoah PD; Whittemore AS; McGuire V; Quaye L; Anton-Culver H; Ziogas A; Terry KL; Cramer DW; Hankinson SE; Tworoger SS; Calingaert B; Chanock S; Sherman M; Garcia-Closas M;
Cancer Res; 2009 Mar; 69(6):2349-57. PubMed ID: 19276375
[TBL] [Abstract][Full Text] [Related]
11. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study.
Doherty JA; Rossing MA; Cushing-Haugen KL; Chen C; Van Den Berg DJ; Wu AH; Pike MC; Ness RB; Moysich K; Chenevix-Trench G; Beesley J; Webb PM; Chang-Claude J; Wang-Gohrke S; Goodman MT; Lurie G; Thompson PJ; Carney ME; Hogdall E; Kjaer SK; Hogdall C; Goode EL; Cunningham JM; Fridley BL; Vierkant RA; Berchuck A; Moorman PG; Schildkraut JM; Palmieri RT; Cramer DW; Terry KL; Yang HP; Garcia-Closas M; Chanock S; Lissowska J; Song H; Pharoah PD; Shah M; Perkins B; McGuire V; Whittemore AS; Di Cioccio RA; Gentry-Maharaj A; Menon U; Gayther SA; Ramus SJ; Ziogas A; Brewster W; Anton-Culver H; ; ; Pearce CL;
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):245-50. PubMed ID: 20056644
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium.
Kelemen LE; Goodman MT; McGuire V; Rossing MA; Webb PM; ; Köbel M; Anton-Culver H; Beesley J; Berchuck A; Brar S; Carney ME; Chang-Claude J; Chenevix-Trench G; ; Cramer DW; Cunningham JM; Dicioccio RA; Doherty JA; Easton DF; Fredericksen ZS; Fridley BL; Gates MA; Gayther SA; Gentry-Maharaj A; Høgdall E; Kjaer SK; Lurie G; Menon U; Moorman PG; Moysich K; Ness RB; Palmieri RT; Pearce CL; Pharoah PD; Ramus SJ; Song H; Stram DO; Tworoger SS; Van Den Berg D; Vierkant RA; Wang-Gohrke S; Whittemore AS; Wilkens LR; Wu AH; Schildkraut JM; Sellers TA; Goode EL;
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1822-30. PubMed ID: 20570913
[TBL] [Abstract][Full Text] [Related]
13. Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes.
Fridley BL; Jenkins GD; Tsai YY; Song H; Bolton KL; Fenstermacher D; Tyrer J; Ramus SJ; Cunningham JM; Vierkant RA; Chen Z; Chen YA; Iversen E; Menon U; Gentry-Maharaj A; Schildkraut J; Sutphen R; Gayther SA; Hartmann LC; Pharoah PD; Sellers TA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):529-36. PubMed ID: 22302016
[TBL] [Abstract][Full Text] [Related]
14. Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.
Ow GS; Ivshina AV; Fuentes G; Kuznetsov VA
Cell Cycle; 2014; 13(14):2262-80. PubMed ID: 24879340
[TBL] [Abstract][Full Text] [Related]
15. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
Pearce CL; Wu AH; Gayther SA; Bale AE; ; Beck PA; Beesley J; Chanock S; Cramer DW; DiCioccio R; Edwards R; Fredericksen ZS; Garcia-Closas M; Goode EL; Green AC; Hartmann LC; Hogdall E; Kjaer SK; Lissowska J; McGuire V; Modugno F; Moysich K; Ness RB; Ramus SJ; Risch HA; Sellers TA; Song H; Stram DO; Terry KL; Webb PM; Whiteman DC; Whittemore AS; Zheng W; Pharoah PD; Chenevix-Trench G; Pike MC; Schildkraut J; Berchuck A;
Br J Cancer; 2008 Jan; 98(2):282-8. PubMed ID: 18219286
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
[TBL] [Abstract][Full Text] [Related]
17. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.
Charbonneau B; Block MS; Bamlet WR; Vierkant RA; Kalli KR; Fogarty Z; Rider DN; Sellers TA; Tworoger SS; Poole E; Risch HA; Salvesen HB; Kiemeney LA; Baglietto L; Giles GG; Severi G; Trabert B; Wentzensen N; Chenevix-Trench G; ; Whittemore AS; Sieh W; Chang-Claude J; Bandera EV; Orlow I; Terry K; Goodman MT; Thompson PJ; Cook LS; Rossing MA; Ness RB; Narod SA; Kupryjanczyk J; Lu K; Butzow R; Dörk T; Pejovic T; Campbell I; Le ND; Bunker CH; Bogdanova N; Runnebaum IB; Eccles D; Paul J; Wu AH; Gayther SA; Hogdall E; Heitz F; Kaye SB; Karlan BY; Anton-Culver H; Gronwald J; Hogdall CK; Lambrechts D; Fasching PA; Menon U; Schildkraut J; Pearce CL; Levine DA; Kjaer SK; Cramer D; Flanagan JM; Phelan CM; Brown R; Massuger LF; Song H; Doherty JA; Krakstad C; Liang D; Odunsi K; Berchuck A; Jensen A; Lubinski J; Nevanlinna H; Bean YT; Lurie G; Ziogas A; Walsh C; Despierre E; Brinton L; Hein A; Rudolph A; Dansonka-Mieszkowska A; Olson SH; Harter P; Tyrer J; Vitonis AF; Brooks-Wilson A; Aben KK; Pike MC; Ramus SJ; Wik E; Cybulski C; Lin J; Sucheston L; Edwards R; McGuire V; Lester J; du Bois A; Lundvall L; Wang-Gohrke S; Szafron LM; Lambrechts S; Yang H; Beckmann MW; Pelttari LM; Van Altena AM; van den Berg D; Halle MK; Gentry-Maharaj A; Schwaab I; Chandran U; Menkiszak J; Ekici AB; Wilkens LR; Leminen A; Modugno F; Friel G; Rothstein JH; Vergote I; Garcia-Closas M; Hildebrandt MA; Sobiczewski P; Kelemen LE; Pharoah PD; Moysich K; Knutson KL; Cunningham JM; Fridley BL; Goode EL
Cancer Res; 2014 Feb; 74(3):852-61. PubMed ID: 24272484
[TBL] [Abstract][Full Text] [Related]
18. Inherited determinants of ovarian cancer survival.
Goode EL; Maurer MJ; Sellers TA; Phelan CM; Kalli KR; Fridley BL; Vierkant RA; Armasu SM; White KL; Keeney GL; Cliby WA; Rider DN; Kelemen LE; Jones MB; Peethambaram PP; Lancaster JM; Olson JE; Schildkraut JM; Cunningham JM; Hartmann LC
Clin Cancer Res; 2010 Feb; 16(3):995-1007. PubMed ID: 20103664
[TBL] [Abstract][Full Text] [Related]
19. Association of Somatic Mutations of ADAMTS Genes With Chemotherapy Sensitivity and Survival in High-Grade Serous Ovarian Carcinoma.
Liu Y; Yasukawa M; Chen K; Hu L; Broaddus RR; Ding L; Mardis ER; Spellman P; Levine DA; Mills GB; Shmulevich I; Sood AK; Zhang W
JAMA Oncol; 2015 Jul; 1(4):486-94. PubMed ID: 26181259
[TBL] [Abstract][Full Text] [Related]
20. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
